CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
104568-67-4 | 2-(3,4-dihydro-6-((3-pyridinylcarbonyl)oxy)-2,5,7,8-3-pyridinecarboxylic aci | |
| |
104568-55-0 | 3-pyridinecarboxylic acid, 2-(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2h-1-be | |
| |
104567-72-8 | emd 21388 | |
| |
104561-36-6 | rwj 20257 | |
| |
10456-86-7 | n-(2-benzoyl-4-chlorophenyl)-glycin ethyl ester | |
| |
10456-80-1 | n-(2-benzoyl-4-nitrophenyl)-glycin ethyl ester | |
| |
10456-50-5 | 17,20-dihydroxy-4-pregnen-3-one | |
| |
104559-06-0 | exell | |
| |
104558-93-2 | cid 85 | |
| |
104558-30-7 | cdc31 protein | |
| |
104554-66-7 | (5-nitro-3-thienyl)-propanedioic aci | |
| |
104548-30-3 | oxone tetrabutylammonium salt | 熔点:144-146℃
|
C80H183N5O18S4 | 1631.6 |
104545-48-4 | 2-pyridinecarboxamide, n-(2-(((2,5-dihydro-2,2,5,5-tetramethyl-1h-pyrrol-3-yl)c | |
| |
104544-35-6 | 5-methyl-7-(2,6-dimethyl-6-ethoxycarbonyl-3-oxo-1-cyclohexyl)-2,4,6-heptatrieno | |
| |
104540-42-3 | 2-溴-3-氟三氟甲苯 2-Bromo-1-fluoro-3-(trifluoromethyl)benzene | 密度:1.741 g/mL at 25 °C 沸点:167℃
|
C7H3BrF4 | 243 |
104538-33-2 | n-[2-(hexylthio)ethyl]-propanamid | |
| |
104530-16-7 | (+)-camphanic acid chloride | 密度:1.298±0.06 g/cm3(Predicted) 熔点:67-70℃ 沸点:299.5±23.0 °C(Predicted)
|
C10H13ClO3 | 216.66 |
10453-89-1 | 菊甲酸 2,2-Dimethyl-3-(2-methyl-1-propenyl)cyclopropane carboxylic acid | 密度:0.9812 g/cm3 (rough estimate) 熔点:50-51 °C 沸点:257.18 °C (rough estimate)
|
C10H16O2 | 168.23 |
10453-86-8 | 苄呋菊酯 Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methylpropenyl)-, (5-benzyl-3-furyl) methyl ester | |
C22H26O3 | 338.44 |
10453-55-1 | 2,2-dimethyl-3-(2-methyl-1-propenyl)-cyclopropanecarboxylic aci (5-(phenylm | |
| |
10453-16-4 | quinidine lactate | |
| |
104527-98-2 | (4R-2-oxazolidinon | |
| |
104527-96-0 | (4S-2-oxazolidinon | |
| |
104525-00-0 | 3-propanediol, 2-((benzo(a)pyren-6-ylmethyl)amino)-2-methyl- methanesulfonat | |
| |
104521-01-9 | c-flex | |
| |
104519-28-0 | 2-(4-butyl-3,5-dimethyl-1h-pyrazol-1-yl)-6-chloro-benzothiazol | |
| |
104519-27-9 | 2-(4-butyl-3,5-dimethyl-1h-pyrazol-1-yl)-6-methyl-benzothiazol | |
| |
104519-26-8 | 2-(4-butyl-3,5-dimethyl-1h-pyrazol-1-yl)-benzothiazol | |
| |
104516-98-5 | 3,5-dimethyl-bicyclo[2.2.1]heptane-2-carbonitril | |
| |
104516-97-4 | 1,3-dimethyl-bicyclo[2.2.1]heptane-2-carbonitril | |
| |
104515-79-9 | 2,3,6,7-Tetrakis(ethylthio)tetrathiafulvalene | |
C14H20S8 | 444.79 |
104514-74-1 | n-(4-vinyl-1,3-thiazolidin-2-ylidene)phenylamine | |
| |
104514-01-4 | 4,5-dihydro-4,5,9-trichloro-pyren | |
| |
104504-45-2 | h-p-bz-phe-oh | 沸点:467.6°C
|
C16H15NO3 | 269.30 |
104504-43-0 | boc-4-benzoyl-l-phenylalanine | |
C21H23NO5 | 369.41 |
104504-42-9 | ac-p-bz-d-phe-oh | |
C18H17NO4 | 311.33 |
104504-34-9 | hepatitis b virus pre-s region*(120-145) | |
C135H199N39O38S | 3008.36 |
104502-50-3 | 3-bromo-4,5-dimethyl-5-(4-morpholinylmethyl)-2(5h)-furanon | |
| |
104502-49-0 | 3-bromo-5-((hexahydro-1h-azepin-1-yl)methyl)-4,5-dimethyl-2(5h)-furanon | |
| |
104502-48-9 | 3-bromo-4,5-dimethyl-5-(1-pyrrolidinylmethyl)-2(5h)-furanon | |
| |
104502-47-8 | 3-bromo-5-((dimethylamino)methyl)-4,5-dimethyl-2(5h)-furanon | |
| |
104502-46-7 | 3-chloro-4,5-dimethyl-5-(4-morpholinylmethyl)-2(5h)-furanon | |
| |
104502-45-6 | 3-chloro-5-((hexahydro-1h-azepin-1-yl)methyl)-4,5-dimethyl-2(5h)-furanon | |
| |
104502-43-4 | 3-chloro-5-((dimethylamino)methyl)-4,5-dimethyl-2(5h)-furanon | |
| |
104500-31-4 | 3-propanediol, 2-((6-acephenanthrylenylmethyl)amino)-2-methyl- methanesulfon | |
| |
104500-28-9 | 2-(((4,5-dihydro-6-acephenanthrylenyl)methyl)amino)-2-methyl-3-propanediol | |
| |
104500-26-7 | 2-((4h-cyclopenta(def)phenanthren-1-ylmethyl)amino)-2-methyl-3-propanediol | |
| |
104500-23-4 | 3-propanediol, 2-((benz(a)anthracen-3-ylmethyl)amino)-2-methyl- methanesulfo | |
| |
104500-15-4 | 3-propanediol, 2-((benzo(c)phenanthren-5-ylmethyl)amino)-2-methyl- methanesu | |
| |
104500-13-2 | 3-propanediol, 2-((11h-benzo(b)fluoren-5-ylmethyl)amino)-2-methyl- methanesu | |
| |